← All CSP Flashcard Decks

Patient Adherence and Outcomes Flashcards

6 cards from real CSP practice questions. Tap to flip, then mark Knew It or Still Learning — missed cards come back until you master them.

Read the first 6 Patient Adherence and Outcomes flashcards as text
  1. When measuring medication adherence using pharmacy claims data, which metric is generally preferred by quality organizations like the Pharmacy Quality Alliance (PQA) because it avoids overestimating adherence in patients who refill prescriptions early?

    Answer: Proportion of Days Covered (PDC)

    Proportion of Days Covered (PDC) is often preferred over Medication Possession Ratio (MPR) because it caps the daily value at 1, preventing the numerator (days covered) from exceeding the denominator (days in the period) and thus avoiding an overestimation of adherence. Quality organizations like PQA and the National Committee for Quality Assurance (NCQA) use PDC for their performance measures.

  2. A patient with Crohn's disease on a self-injectable biologic frequently misses doses. During a follow-up call, the patient states, "I just get so anxious about giving myself the shot, and it stings. I keep putting it off." This represents which type of adherence barrier?

    Answer: Therapy-related barrier

    The patient's non-adherence is directly linked to the characteristics of the therapy itself—the pain and anxiety associated with the self-injection process. This falls under the category of therapy-related barriers, which also includes side effects and regimen complexity.

  3. A specialty pharmacist is counseling a patient who expresses ambivalence about starting a new oral medication for multiple sclerosis due to a fear of potential side effects. Which of the following statements best exemplifies the use of Motivational Interviewing (MI)?

    Answer: "It sounds like you're concerned about how the side effects might impact your daily life, but you're also hopeful this could prevent a relapse. Could we talk more about that balance?"

    This statement uses a key MI technique called a "double-sided reflection." It acknowledges and validates the patient's concerns (the "con" of taking the medication) while also reflecting their potential motivation for taking it (the "pro"), encouraging them to explore their own ambivalence without judgment or confrontation.

  4. A specialty pharmacy aims to enhance its adherence program for patients taking oral medications for pulmonary arterial hypertension. Which of the following technology-based interventions is most likely to improve patient outcomes?

    Answer: Implementing a mobile application with personalized dose reminders, educational content, and a feature for tracking side effects.

    Interactive, patient-centered technology like a comprehensive mobile app is most effective. It actively engages the patient with personalized reminders, provides easily accessible information, and allows for self-monitoring, which can improve both adherence and self-management skills, leading to better outcomes. Passive or burdensome interventions are less effective.

  5. A patient being treated with a direct-acting antiviral (DAA) for Hepatitis C has a Proportion of Days Covered (PDC) of 70% during their 12-week treatment course. This level of adherence is most strongly associated with which of the following outcomes?

    Answer: A significantly increased risk of virologic failure.

    Achieving a sustained virologic response (SVR), or a cure, with DAA therapy is highly dependent on near-perfect adherence. A PDC of 70% constitutes significant non-adherence and dramatically increases the risk of treatment failure, where the virus is not eradicated from the body. While resistance is a concern, the most direct and likely outcome is failing to achieve a cure.

  6. In the context of a specialty pharmacy's patient management program, which activity best demonstrates the pharmacist's role in improving patient outcomes beyond simply measuring adherence?

    Answer: Proactively assessing for side effects and collaborating with the prescriber to manage them.

    Improving outcomes requires more than ensuring the patient has the medication. Proactive clinical management, such as assessing and managing side effects, addresses a key therapy-related barrier to adherence. This collaborative action helps the patient tolerate the therapy, remain adherent, and achieve the desired clinical goals, directly impacting their health outcome. The other options are primarily operational or administrative tasks.